Compass Therapeutics, Inc. (CMPX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesGeneral And Administrative Expenses
04M8M11M15M19M22M26M30MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-30M-26M-22M-19M-15M-11M-7M-4M1Q4 2024Q1 2025Q2 2025Q3 2025

EPS

Revenue Variation (%)

Income Variation (%)

Operating Income Variation
0612192531384450Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q2 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
0612192531384450Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-20-17-15-12-10-7-4-21Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0500K1M2M2M2M3M4M4MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
01K2K3K4K6K7K8K9KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Free Cash Flow

Cash At End Of Period
08M15M22M30M38M45M52M60MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
025M50M75M100M125M150M175M200MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics